tisocromide (Impavido)

Subscribe to Selected New Research on tisocromide

3 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure

Also Known As:

Impavido; (4-dimethylamino-4-methylpentyl-2-carbamoyl)-6,7-dimethoxy-1-thioisochroman 1,1-dioxide; 16-2443; tisochromid; N-(3-(dimethylamino)-1,3-dimethylbutyl)-3,4-dihydro-6,7-dimethoxy-2,1-benzoxathiin-3-carboxamide- 1,1-dioxide

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Oxathiins

tisocromide: 3

Experts

1.	Unger, C: 1 article (11/2004)
2.	Croft, S L: 1 article (11/2004)
3.	Engel, J: 1 article (11/2004)
4.	Sindermann, H: 1 article (11/2004)
5.	Eibl, H J: 1 article (11/2004)
6.	Engel, K R: 1 article (11/2004)
7.	Bommer, W: 1 article (11/2004)

Related Diseases

1.	Cutaneous Leishmaniasis 04/01/2007 - "Other alkylphospholipids have been previously used as antileishmanial agents, and miltefosine (Impavido) is now established as the first oral drug for the treatment of visceral and cutaneous leishmaniasis" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 01/01/2004 - "Hexadecylphosphocholine (HDPC, Miltefosine, Impavido) was synthesized at the Max-Planck-Institut für Biophysikalische Chemie in Göttingen, Germany and successfully used for the therapy of cancer metastases" Get all the results and reference details, order at left...
3.	Neoplasm Metastasis (Metastasis) 01/01/2004 - "Hexadecylphosphocholine (HDPC, Miltefosine, Impavido) was synthesized at the Max-Planck-Institut für Biophysikalische Chemie in Göttingen, Germany and successfully used for the therapy of cancer metastases" Get all the results and reference details, order at left...
4.	Visceral Leishmaniasis (Kala Azar) 01/01/2004 - "In India Impavido has been recently registered for the treatment of visceral leishmaniasis as the first oral medication in this indication" Get all the results and reference details, order at left...
5.	Leishmaniasis 11/01/2004 - "Miltefosine (Impavido): the first oral treatment against leishmaniasis." Get all the results and reference details, order at left...
5 Diseases and 3 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	miltefosine
1 Drugs and Important Bio-Agents and 3 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>